Potential health risks of complementary alternative medicines in cancer patients

被引:155
作者
Werneke, U
Earl, J
Seydel, C
Horn, O
Crichton, P
Fannon, D
机构
[1] Homerton Hosp, Dept Psychiat, London E9 6SR, England
[2] Inst Psychiat, Ctr Econ Mental Hlth, London SE5 8AJ, England
[3] Royal Marsden Hosp, Dept Pharm, Sutton SM2 5PT, Surrey, England
[4] Univ London Kings Coll, Sch Med & Dent, Acad Dept Psychol Med, London SE5 8AF, England
[5] Inst Psychiat, London SE5 8AF, England
[6] Royal Marsden Hosp, Dept Psychol Med, Sutton SM2 5PT, Surrey, England
[7] Maudsley Hosp & Inst Psychiat, London SE5 8AZ, England
[8] Inst Psychiat, Div Psychol Med, London SE5 8AZ, England
关键词
complementary alternative medicines; herbal remedies; supplements; cancer; risks; echinacea;
D O I
10.1038/sj.bjc.6601560
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many cancer patients use complementary alternative medicines (CAMs) but may not be aware of the potential risks. There are no studies quantifying such risks, but there is some evidence of patient risk from case reports in the literature. A cross-sectional survey of patients attending the outpatient department at a specialist cancer centre was carried out to establish a pattern of herbal remedy or supplement use and to identify potential adverse side effects or drug interactions with conventional medicines. If potential risks were identified, a health warning was issued by a pharmacist. A total of 318 patients participated in the study. Of these, 164 (51.6%) took CAMs, and 133 different combinations were recorded. Of these, 10.4% only took herbal remedies, 42.1% only supplements and 47.6% a combination of both. In all, 18 (11.0%) reported supplements in higher than recommended doses. Health warnings were issued to 20 (12.2%) patients. Most warnings concerned echinacea in patients with lymphoma. Further warnings were issued for cod liver/fish oil, evening primrose oil, gingko, garlic, ginseng, kava kava and beta-carotene. In conclusion, medical practitioners need to be able to identify the potential risks of CAMs. Equally, patients should be encouraged to disclose their use. Also, more research is needed to quantify the actual health risks.
引用
收藏
页码:408 / 413
页数:6
相关论文
共 39 条
  • [1] Aradhana M., 1992, Int. J. Exp. Biol., V30, P367
  • [2] Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians
    Ashikaga, T
    Bosompra, K
    O'Brien, P
    Nelson, L
    [J]. SUPPORTIVE CARE IN CANCER, 2002, 10 (07) : 542 - 548
  • [3] AUSTIN JAL, 1998, JAMA-J AM MED ASSOC, V20, P1547
  • [4] Bernstein BJ, 2001, ONCOLOGY-NY, V15, P1267
  • [5] NUTRITION INTERVENTION TRIALS IN LINXIAN, CHINA - SUPPLEMENTATION WITH SPECIFIC VITAMIN MINERAL COMBINATIONS, CANCER INCIDENCE, AND DISEASE-SPECIFIC MORTALITY IN THE GENERAL-POPULATION
    BLOT, WJ
    LI, JY
    TAYLOR, PR
    GUO, WD
    DAWSEY, S
    WANG, GQ
    YANG, CS
    ZHENG, SF
    GAIL, M
    LI, GY
    YU, Y
    LIU, BQ
    TANGREA, J
    SUN, YH
    LIU, FS
    FRAUMENI, JF
    ZHANG, YH
    LI, B
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (18): : 1483 - 1492
  • [6] Acute liver failure after administration of the herbal tranquilizer kava-kava (Piper methysticum)
    Brauer, RB
    Stangl, M
    Siewert, JR
    Pfab, R
    Becker, K
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (02) : 216 - 218
  • [7] BROX JH, 1981, THROMB HAEMOSTASIS, V46, P604
  • [8] Potential physician malpractice liability associated with complementary and integrative medical therapies
    Cohen, MH
    Eisenberg, DM
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (08) : 596 - 603
  • [9] FAILURE OF HIGH-DOSE VITAMIN-C (ASCORBIC-ACID) THERAPY TO BENEFIT PATIENTS WITH ADVANCED CANCER - CONTROLLED TRIAL
    CREAGAN, ET
    MOERTEL, CG
    OFALLON, JR
    SCHUTT, AJ
    OCONNELL, MJ
    RUBIN, J
    FRYTAK, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (13) : 687 - 690
  • [10] Pharmacogenetics of oral anticoagulants
    Daly, AK
    King, BP
    [J]. PHARMACOGENETICS, 2003, 13 (05): : 247 - 252